NEW YORK—Investor relations firm FD Morgen-Walke has formed a global life sciences practice, designed to provide clients in the healthcare field with integrated, cross-border communications services. The practice is comprised of 40 specialists and will draw on capabilities in the firm’s New York, Boston and San Francisco offices.
The team covers the life sciences spectrum, including pharmaceuticals, medical devices, diagnostics, drug discovery, women’s healthcare and bioscience venture capital. Current clients include GlaxoSmithKline, Amersham, Smith & Nephew, Shire Pharmaceuticals, Alcon Laboratories and Watson Pharmaceuticals as well as small and medium-sized enterprises.
“Life sciences is a growing business for FD International and a core practice for FD Morgen-Walke in the U.S.,” said Anton Nicholas, COO and senior managing director. “The launch of our global practice is a direct response to our clients’ demands for integrated, cross-border representation and will better enable us to serve clients with comprehensive service.”
The firm has also hired Sean Leous as an assistant vice president in New York. A specialist in healthcare media relations, Leous was previously an assistant vice president, investor and media relations for the medical group at Lippert/Heilshorn & Associates and earlier, at Porter LeVay & Rose.